Stanley S. Scott Cancer Center Invited Speaker Series(Supported
by the
Louisiana Cancer Research Consortium)
(Sponsored
CME
series)
Time
&
Location:
1st & 3rd Thursday at Noon LSU Health Sciences Center Clinical Science Research Building (unless otherwise noted) 533 Bolivar St., Room 563 Map/Directions - Contact Remote Access Grid Locations: ( If you are interested in attending at one of the below locations, please email the Access Grid contact for your respective site.)
Statement of Need: The purpose of the Stanley S. Scott Cancer Center (SSSCC) Invited Speaker Series is to fulfill an educational need in the local community by providing the latest research and findings in the field of oncology. In this capacity the series serves to build upon the competencies of those in attendance as a resource for information on research and treatment protocols. Communication among physicians and researchers to share their experiences in clinical and laboratory settings is encouraged to foster an atmosphere of collaboration. Presentations and discussion of current topics helps to keep audience members informed on the latest research and developments in cancer diagnosis and treatment. Target Audience: The target audience for this activity includes oncologists, hematologists, nurses, techs, medical students, and health care providers with an interest in cancer treatment and research. Objectives: After participating in this educational activity, the attendee should be better able to:
Accreditation/Designation of Credit: LSU School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. LSU School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
LSU School of Medicine presents this activity for educational purposes only and does not endorse any product, content of presentation or exhibit. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected because of their recognized expertise.
Facilitated by: The LSU Health Sciences Center – Institute of Professional Education
Faculty
Disclosure: It is the
policy of
Continuing Education at LSU School of Medicine to plan and implement
all of its educational activities in accordance with the ACCME's
Essential Areas and Policies to ensure balance, independence,
objectivity and scientific rigor. In accordance with the ACCME's 2004
Standards for Commercial Support, everyone who is in a position to
control the content of an educational activity certified for AMA
PRA Category 1 Credit™ is required to disclose all relevant
financial relationships with any commercial interests within the past
12 months that creates a real or apparent conflict of interest.
Individuals who do not disclose are disqualified from participating in
a CME activity. Individuals with potential for influence or control of
CME content include planners and planning committee members, authors,
teachers, educational activity directors, educational partners, and
others who participate, e.g. facilitators and moderators. This
disclosure pertains to relationships with pharmaceutical companies,
biomedical device manufacturers or other corporations whose products or
services are related to the subject matter of the presentation topic.
Any real or apparent conflicts of interest related to the content of
the presentations must be resolved prior to the educational activity.
Disclosure of off-label, experimental or investigational drugs or
devices must also be made known to the audience.
Speaker
Schedule
for 2011
|
|
Date |
Speaker |
Title |
| Feb
3 |
Lucia
Pirisi-Creek, MD Professor Department of Pathology University of South Carolina |
"The Carolina Women's Care Study: Determinants and Biomarkers of Persistent HPV Infection in College-Age Women" |
| Mar
17 |
Christopher
H.
Parsons, MD Assistant Professor Department of Medicine Medical University of South Carolina |
"New Paradigms for HIV-Associated Viral Cancer Pathogenesis and Treatment" |
| May
5 |
Danilo
Perrotti,
MD, PhD Associate Professor Department of Molecular Virology, Immunology, and Medical Genetics Ohio State University |
"The Tumor Suppressor PP2A as a Therapeutic Target for Eradication of TKI-resistant Ph+ Leukemic Stem Cells" |
| May
19 |
Federico
Monzon,
MD Assistant Professor Pathology and Laboratory Medicine Methodist Hospital Research Institute |
"Clinical Cancer
Diagnostics with SNP Cytogenomic Arrays" |
| Aug
29 |
Tomasz
Skorski, MD, PhD, DSc Professor Dept of Microbiology and Immunology Temple University School of Medicine |
"Enhanced Oxidative
DNA Damage in CML Stem Cells: Should We Inhibit It to Prevent
Genomic Instability or Use It to Eliminate TKI-Refractory Cells?" |
| Oct
20 |
Daniel
Levitt, MD, PhD Chief Medical Officer CytRx Corporation |
"Using Albumin to
Carry Cancer Drugs Into Tumors" |
| Speaker Schedule for 2010 | ||
|
Date |
Speaker |
Title |
|
Feb 4 |
William
H.
Matsui,
MD
Associate Professor of Oncology Sidney Kimmel Comprehensive Cancer Center John Hopkins University School of Medicine |
"Stem Cell Concepts in Cancer" |
|
Mar 4 |
Zena
Werb,
PhD Professor and Vice-Chair Department of Anatomy University of California |
"Of Mice and Women: How Studying Mammary Development Gives Us Insights Into Breast Cancer" |
|
May 20 |
Cezary
Marcinkiewicz,
PhD Associate Professor Department of Biology Temple University |
"Regulation of Glioma Progression by the Ligands of a9ß1 Integrin" |
|
May 27 |
Kapil
N.
Bhalla,
MD,
FACP
Professor School of Medicine Medical College of Georgia |
"Targeting the Nexus of Heat Shock and Proteotoxic Stress Responses in Cancer" |
|
Oct 7 |
David
Berz,
MD,
PhD,
MPH
Assistant Professor Warren Alpert Medical School Brown University |
"Non Small Cell Lung Cancer - A
Misnomer" |
|
Oct 21 |
Ethan
Dmitrovsky,
MD
Andrew G. Wallace Professor of Medicine and Pharmacology Department of Medicine Norris Cotton Cancer Center |
"Bidirectional Translation
Research for Lung Cancer" |
|
Nov 4 |
Varsha
Gandhi,
PhD Professor Department of Leukemia University of Texas M.D. Anderson Cancer Center |
"Targeting Bcl-2 Survival
Proteins: A New Concept in Chemotherapy" |
| |
||
|
Nov 18 |
Yi
Zheng,
PhD Professor Department of Pediatrics University of Cincinnati College of Medicine |
"Rho GTPases: Physiological
Functions and Translational Implications" |
| |
||
|
Dec 2 |
Ravindra
Majeti,
MD,
PhD Assistant Professor of Medicine Division of Hematology Stanford University |
"Targeting CD47 with Blocking
Monoclonal Antibodies in Hematologic Malignancies" |
|
Dec 16 |
Susan
A.
Melin,
M.D. Associate Professor Section of Hematology and Oncology Wake Forest University School of Medicine |
"Avastin in Breast Cancer" |
Joshua Lovell
Phone: 504-568-2728
email: jlove1@lsuhsc.edu
Academic Coordinator for the Invited Speaker Series:
John Estrada, MD
email: jestra@lsuhsc.edu
|
||||||||||||
